医学
指南
偏头痛
重症监护医学
梅德林
临床实习
偏头痛
物理疗法
血管扩张剂
药物治疗
循证医学
替代医学
临床试验
作者
Sonja Potrebic,Sarah Tanveer,Werner J. Becker,Rebecca C. Burch,Lara Cooke,Todd Fenton,Jeffrey James Fletcher,Gillian Gordon Perue,Andrew D. Hershey,Jeffrey L. Jackson,Shirley Kessel,Elizabeth Loder,Mia Tova Minen,Maryam Oskoui,Vijay K. Ramanan,Michelle Murren,Todd J. Schwedt,Stephen D. Silberstein,Don B. Smith,Kylie A. Botchway-Doe
出处
期刊:Neurology
[Lippincott Williams & Wilkins]
日期:2026-08-31
卷期号:107 (7): e214881-e214881
被引量:4
标识
DOI:10.1212/wnl.0000000000214881
摘要
This practice guideline provides updated evidence-based recommendations regarding the use of pharmacologic migraine prevention in adults. A multidisciplinary panel conducted a systematic review and developed practice recommendations following the process outlined in the 2017 edition of the American Academy of Neurology Clinical Practice Guideline Process Manual. The systematic review includes studies published through June 6, 2024, and is available in a companion publication. Recommendations are supported by structured rationales that integrate evidence from the systematic review, related evidence, principles of care, and inferences from evidence. Recommendations are provided on how to decide when it is appropriate to start a pharmacologic migraine preventive medication and how to decide which migraine preventive medication to start. Recommendations address decision making on appropriate choices of migraine preventive medications in specific situations and populations, including patients with fibromyalgia, obesity, or hypertension; considerations for older adults; treatment during pregnancy and lactation; sex-related factors in choosing medications; and treatment for patients with medication overuse. Recommendations on assessment of treatment efficacy, adverse effects, and discontinuing migraine preventive medications are provided.
科研通智能强力驱动
Strongly Powered by AbleSci AI